펩타이드 살충제 시장은 2025년에 20억 4,000만 달러로 평가되었으며, 2026년에는 22억 6,000만 달러로 성장하여 CAGR 11.72%를 기록하며 2032년까지 44억 4,000만 달러에 달할 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 2025년 | 20억 4,000만 달러 |
| 추정 연도 2026년 | 22억 6,000만 달러 |
| 예측 연도 2032년 | 44억 4,000만 달러 |
| CAGR(%) | 11.72% |
펩타이드 살충제는 생명공학과 작물보호를 융합한 최첨단 분야로, 단쇄 아미노산을 기반으로 표적 생물 활성을 발휘하며, 많은 기존 화학농약에 비해 비표적 생물에 대한 영향을 줄일 수 있는 잠재력을 가지고 있습니다. 연구자와 제품 개발자들은 해충의 생리적 기능을 억제하고, 식물의 저항성을 높이고, 정밀한 적용을 실현하는 디지털 농업 접근 방식과 통합하는 수단으로 펩타이드를 추진해 왔습니다. 농업 시스템이 해충 저항성, 규제 당국의 모니터링, 지속가능성에 대한 노력과 같은 증가하는 압력에 직면하고 있는 가운데, 펩타이드는 종합적인 해충 관리 원칙과 환경 부하 감소 요구사항에 부합하는 대안을 제시합니다.
펩타이드 살충제의 전망은 여러 요인이 수렴하면서 빠르게 변화하고 있습니다. 계산생물학과 펩타이드 설계의 발전으로 활성 서열의 발견 속도와 특이성이 향상되어 표적 외 독성을 감소시키는 표적 지향적 작용 기전이 가능해졌습니다. 그린 케미스트리와 제형 과학의 병행 혁신은 실제 조건에서 펩타이드의 안정성을 향상시키고, 효과적인 방제 기간을 연장하며, 적용 방법의 선택권을 확대합니다. 그 결과, 개발자들은 개념증명 단계의 온실 테스트에서 더 큰 규모의 야외 테스트 및 파일럿 상용화 프로그램으로 전환하고 있습니다.
2025년에 시행된 관세 조치는 특히 전구체 재료, 특수 시약, 합성 장비가 국경을 넘나드는 경우, 펩타이드 살충제 밸류체인에 새로운 복잡성을 야기했습니다. 이러한 세금 부과로 인해 특정 수입 투입물의 착륙 비용이 증가하여 조달 팀은 공급업체 포트폴리오를 재평가해야 합니다. 이에 따라 일부 제조업체들은 주요 부품의 현지 조달을 가속화하거나 공급업체 인증 프로그램을 확대하여 위험을 분산시키고 있습니다. 이로 인해, 특히 실험실 규모의 펩타이드 합성에서 대규모 상업적 배치 생산으로 전환하는 제조업체의 경우, 비용 구조와 스케일업 활동의 타이밍을 재검토하고 있습니다.
작물 유형의 차이를 살펴보면, 농업 부문별로 기술적, 상업적 요구사항이 크게 다르다는 것을 알 수 있습니다. 곡물, 유지종자, 콩류 등 밭작물에서는 대규모 기계화 살포 및 종자 처리 물류에 대응하는 비용 효율적인 광역 살포 솔루션이 요구됩니다. 이에 반해 과수-채소(채소는 과채류, 엽채류, 근채류로 분류)는 수확시기, 잔류규제, 다양한 수관구조를 고려한 제제가 필요합니다. 화훼, 잔디, 관상용 식물은 외관 효과와 낮은 식물 독성을 우선시하기 때문에 제제의 내성과 살포 빈도에 영향을 미칩니다.
아메리카에서는 농업 시스템이 규모와 기계화를 중시하기 때문에 광활한 밭작물과 대규모 과수 재배에 적합한 제형과 살포 방법을 선호합니다. 주요 관할권 규제 당국은 투명한 유효성 데이터와 환경 안전성 평가를 중시하면서 신규 바이오 농약에 대한 대응을 지속적으로 정교화하고 있습니다. 이러한 규제 환경은 강력한 농업 연구 개발 인프라와 확립된 유통 네트워크와 함께 개발자와 작물보호제 유통업체 간의 협력적인 현장 검사 프로그램 및 전략적 제휴를 촉진하고 있습니다.
주요 기업들은 기반 과학기술, 제형 기술, 전략적 제휴의 조합을 통해 차별화를 꾀하고 있습니다. 모듈형 신약개발 플랫폼과 고성능 스크리닝에 투자하는 기업은 선도 화합물 발굴을 가속화하면서 다른 표적 해충이나 작물로 유연하게 전환할 수 있는 여지를 확보할 수 있습니다. 이들 조직은 제제 화학 분야의 상호보완적인 강점을 바탕으로 실험실에서 검증된 펩타이드를 살포 요건과 잔류 기준을 충족하는 안정적인 현장 적용 제품으로 전환할 수 있습니다. 계약 연구기관, 전문 제제 제조업체, 유통 네트워크와의 제휴는 역량 격차를 해소하고 파일럿 프로그램의 실제 도입까지 걸리는 시간을 단축하는 데 필수적입니다.
프로젝트 시작부터 신약 개발 노력과 제형 및 규제 전략을 일치시키는 통합 개발 계획을 우선시해야 합니다. 생물학자, 화학자, 제제 기술자, 규제 전문가가 조기에 협력하면 비용이 많이 드는 재수정을 줄이고 실험실에서 현장으로의 전환을 가속화할 수 있습니다. 여러 제형 프로토타입을 병렬로 개발함으로써 각 작물 유형 및 적용 방법에 가장 적합한 전달 방법을 밝힐 수 있습니다. 동시에 규제 당국과의 지속적인 대화를 통해 데이터 요구 사항과 검사 설계를 명확히 할 수 있습니다.
이 조사는 1차 및 2차 증거를 통합하여 펩타이드 살충제의 동역학에 대한 강력한 분석을 구축했습니다. 일차적인 정보원으로는 신약개발 생물학, 제제 과학, 규제 대응, 상업 전략 분야의 전문가들과의 구조화된 인터뷰와 현장 검사 실무자들의 기술 브리핑이 포함됩니다. 2차 자료로는 과학 및 정책적 배경을 뒷받침하는 심사 완료된 문헌, 규제 지침 문서, 특허 출원 서류, 기업 공시 자료 등이 활용되었습니다. 데이터 삼각측량으로 다양한 관점을 반영하여 단일 정보원에 대한 의존도를 줄였습니다.
펩타이드 살충제는 표적 지향성 효과와 우수한 환경적 특성을 결합할 수 있는 가능성을 제시함으로써 작물 보호 분야에서 독보적인 위치를 차지하고 있습니다. 이러한 잠재력을 실현하기 위해서는 신약개발, 제형, 규제 전략, 공급망 설계에 대한 일관성 있는 투자가 필요합니다. 설계 및 제형 기술의 발전으로 보다 신뢰할 수 있는 실제 성능이 실현되고 있지만, 규제 당국의 기대와 진화하는 관세 제도는 미래 지향적인 계획과 적응형 상업화 모델을 요구하고 있습니다. 과학적인 개발과 규제 당국과의 협력, 강력한 조달 관행을 동기화하는 이해관계자들은 시장 출시 시간을 단축하고 상업적 수용 가능성을 높일 수 있을 것으로 보입니다.
The Peptide Pesticides Market was valued at USD 2.04 billion in 2025 and is projected to grow to USD 2.26 billion in 2026, with a CAGR of 11.72%, reaching USD 4.44 billion by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 2.04 billion |
| Estimated Year [2026] | USD 2.26 billion |
| Forecast Year [2032] | USD 4.44 billion |
| CAGR (%) | 11.72% |
Peptide-based pesticides represent a convergent frontier of biotechnology and crop protection, leveraging short chains of amino acids to deliver targeted bioactivity with potentially lower non-target impacts than many conventional chemistries. Researchers and product developers have advanced peptides as tools to disrupt pest physiology, enhance plant resistance, and integrate with digital agriculture approaches for precision application. As agricultural systems face mounting pressures from pest resistance, regulatory scrutiny, and sustainability commitments, peptides offer an alternative modality that aligns with integrated pest management principles and the demand for reduced environmental footprint.
Strategically, stakeholders must navigate a complex interplay of discovery science, formulation engineering, regulatory pathways, and distribution channels. Early-stage innovations hinge on robust biological validation and scalable synthesis, while later-stage commercialization requires formulation stability, field efficacy demonstrations, and clear regulatory dossiers. Consequently, decision-makers should treat peptide pesticides not as a single product class but as a portfolio of technologies requiring coordinated investment across R&D, regulatory affairs, and supply chain capabilities.
The landscape for peptide pesticides is changing rapidly due to several converging forces. Advances in computational biology and peptide design have increased the speed and specificity with which active sequences are discovered, enabling targeted modes of action that reduce off-target toxicity. Parallel innovations in green chemistry and formulation science have improved peptide stability under field conditions, extending effective windows of control and expanding feasible application methods. As a result, developers are moving beyond proof-of-concept greenhouse studies to larger field trials and pilot commercialization programs.
Regulatory frameworks and sustainability imperatives are simultaneously reshaping commercialization pathways. Policymakers are increasingly receptive to active ingredients that demonstrate lower environmental persistence and non-target risk, which benefits peptide approaches that can be designed for biodegradability. At the same time, regulatory expectations for residue analysis, environmental fate, and non-target organism testing require earlier and more integrated planning. Moreover, digital agriculture, precision application technologies, and integrated pest management adoption are altering how peptides are deployed operationally, emphasizing compatibility with foliar, seed, and soil delivery systems and alignment with resistance management strategies.
Tariff measures implemented in 2025 have introduced a new layer of complexity for peptide pesticide value chains, particularly where precursor materials, specialized reagents, and synthesis equipment cross borders. These levies have increased landed costs for certain imported inputs and prompted procurement teams to reassess supplier portfolios. In response, some manufacturers have accelerated localization efforts for key components or expanded supplier qualification programs to diversify risk. This has led to a re-evaluation of cost structures and timing for scale-up activities, especially for manufacturers moving from lab-scale peptide synthesis to larger commercial batches.
Beyond direct input cost effects, tariffs have altered the calculus of strategic partnerships and contract manufacturing. Firms with vertically integrated capabilities or in-region contract manufacturers gained negotiating leverage, while those reliant on cross-border supply chains faced longer lead times and increased inventory carrying decisions. Regulatory submissions and field trial programs also experienced indirect impacts as paperwork and imported reference standards encountered customs delays. Consequently, organizations have prioritized supply chain transparency, multi-sourcing, and nearshoring options to mitigate tariff-related uncertainty while maintaining rigorous quality and compliance standards.
Examining crop type distinctions highlights the divergent technical and commercial requirements across agricultural segments. Field crops, including cereals and grains, oilseeds, and pulses, demand cost-effective, broad-deployment solutions compatible with large-scale mechanized application and seed treatment logistics. Fruits and vegetables present a contrasting profile: fruit crops and vegetables, with vegetables further categorized into fruit vegetables, leafy vegetables, and root vegetables, require formulations that respect harvest windows, residue constraints, and diverse canopy structures. Ornamentals, spanning flowers and turf and ornamentals, prioritize cosmetic outcomes and low phytotoxicity, influencing formulation tolerances and frequency of application.
Product form choices are equally consequential. Emulsions, granules, liquids, and powders each impose different constraints on stability, field handling, and compatibility with machinery. Emulsions and liquids facilitate rapid uptake and foliar delivery, whereas granules and powders may offer advantages for soil treatments and seed coatings. Target pest profiles shape R&D and deployment priorities as well; fungi, insects, nematodes, and weeds each present unique biological challenges that dictate screening strategies, in vitro to in planta translation, and resistance management planning. Mode of action characteristics - whether contact, systemic, translaminar, or vapor action - influence formulation development, application timing, and monitoring for non-target exposure. Finally, application method selection, spanning foliar spray, seed treatment, soil treatment, and trunk injection, ties together crop needs, product form, and mode of action to determine field performance and adoption potential. Integrated planning that aligns crop type, product form, target pest, mode of action, and application method will be the cornerstone of successful peptide pesticide development and market entry.
In the Americas, agricultural systems emphasize scale and mechanization, influencing preferences for formulations and application methods compatible with broadacre field crops and large fruit operations. Regulatory authorities in major jurisdictions continue to refine their approaches to novel biopesticides, with an emphasis on transparent efficacy data and environmental safety assessments. This regulatory environment, combined with strong agricultural R&D infrastructure and established distribution networks, favors coordinated field trial programs and strategic partnerships between developers and crop protection distributors.
Europe, the Middle East, and Africa (EMEA) present a heterogeneous landscape where stringent environmental standards and consumer expectations drive demand for low-residue, biodegradable solutions. EMEA jurisdictions often require robust ecotoxicology and fate studies, which can extend development timelines but also create higher barriers to entry for non-compliant products. Meanwhile, the Middle East and Africa segments show variable adoption patterns driven by local pest pressures, crop mixes, and logistical constraints. Across EMEA, growers prioritize compatibility with integrated pest management programs and traceability across supply chains.
Asia-Pacific markets combine high-intensity horticulture and vast field-crop systems, creating diverse demand signals. Regulatory frameworks in the region vary widely, with some economies streamlining pathways for biopesticides while others maintain conservative approval requirements. Manufacturing capacity and chemical intermediates availability in Asia-Pacific supply chains present both opportunities and vulnerabilities; proximity to synthesis facilities can lower lead times but also concentrates exposure to regional policy shifts. Collectively, these regional dynamics suggest that tailored regulatory strategies, partnership models, and formulation portfolios are essential to achieve product acceptance and sustained use.
Leading organizations are differentiating through a combination of platform science, formulation expertise, and strategic alliances. Firms that invest in modular discovery platforms and high-throughput screening tend to accelerate lead identification while preserving flexibility to pivot toward different target pests or crops. Complementary strengths in formulation chemistry enable these organizations to translate lab-validated peptides into stable, field-ready products that meet application and residue requirements. Partnerships with contract research organizations, specialty formulators, and distribution networks have become essential to bridge capability gaps and shorten time-to-field for pilot programs.
Commercial strategies also reflect varied approaches to intellectual property and regulatory navigation. Some companies prioritize proprietary sequences and synthesis processes, while others adopt collaborative licensing models to expand distribution reach. Firms that proactively align regulatory strategies with evidence-generation plans-incorporating ecotoxicology, residue, and efficacy studies early-can reduce downstream risk and improve stakeholder confidence. In procurement and manufacturing, vertically integrated players or those with secure contract manufacturing relationships benefit from greater control over quality and supply continuity. Ultimately, competitive advantage accrues to organizations that integrate scientific rigor, formulation engineering, regulatory foresight, and nimble commercialization pathways.
Prioritize integrated development plans that align discovery efforts with formulation and regulatory strategy from project inception. Early coordination between biologists, chemists, formulators, and regulatory experts reduces the need for costly rework and accelerates translation from lab to field. Parallel-track development of multiple formulation prototypes can reveal the most viable delivery approach for each crop type and application method, while ongoing dialogue with regulatory authorities helps clarify data expectations and study design.
Invest in diversified supply chains and regional partnerships to mitigate geopolitical and tariff-driven disruptions. Establishing dual sourcing for key reagents, qualifying regional contract manufacturers, and maintaining strategic inventory buffers will reduce vulnerability to border measures and logistical delays. Additionally, pilot programs that combine field efficacy trials with stewardship plans and resistance management frameworks will improve adoption by growers and regulators. Finally, embrace collaborative models-licensing, co-development, or distribution alliances-to scale commercialization efficiently while sharing development risk and leveraging local market expertise.
This research synthesized primary and secondary evidence to produce a robust analysis of peptide pesticide dynamics. Primary inputs included structured interviews with subject-matter experts across discovery biology, formulation science, regulatory affairs, and commercial strategy, as well as technical briefings from practitioners involved in field trials. Secondary inputs consisted of peer-reviewed literature, regulatory guidance documents, patent filings, and company disclosures that informed scientific and policy context. Data triangulation ensured that insights reflected multiple perspectives and reduced reliance on any single information source.
Analytical rigor was maintained through iterative validation cycles. Key findings were cross-checked with technical experts and refined based on feedback from stakeholders engaged in different parts of the value chain. Where appropriate, sensitivity analyses explored how alternative assumptions about supply chain disruptions, regulatory timelines, or formulation performance could influence strategic priorities. Methodological limitations include the evolving nature of regulatory interpretation and ongoing field validation studies; these were explicitly acknowledged and contextualized to avoid overextension of conclusions.
Peptide pesticides occupy a distinct space in crop protection by offering the possibility of targeted efficacy with favorable environmental profiles. Realizing that potential requires aligned investments across discovery, formulation, regulatory strategy, and supply chain design. Technological advances in design and formulation are enabling more reliable field performance, yet regulatory expectations and evolving tariff regimes demand proactive planning and adaptive commercialization models. Stakeholders that synchronize scientific development with regulatory engagement and resilient procurement practices will reduce time-to-field and increase the likelihood of commercial acceptance.
In summary, peptide pesticides will not be a universal replacement for conventional chemistries but will serve as an important complementary toolkit within integrated pest management paradigms. Success will favor organizations that combine technical excellence, strategic partnerships, and operational agility to translate laboratory promise into reliable, scalable solutions for growers.